Literature DB >> 23731607

Periarteritis in lung from a continuous-flow right ventricular assist device: role of the local Renin-Angiotensin system.

Chiyo Ootaki1, Michifumi Yamashita, Yoshio Ootaki, Diyar Saeed, Tetsuya Horai, Hideyuki Fumoto, Alex L Massiello, Steven N Emancipator, Leonard A R Golding, Kiyotaka Fukamachi.   

Abstract

BACKGROUND: We previously reported renal arterial periarteritis after implantation of a continuous-flow left ventricular assist device in calves. The purpose of the present study was to investigate whether the same periarteritis changes occur in the intrapulmonary arteries after implantation of a continuous-flow right ventricular assist device (CFRVAD) in calves and to determine the mechanism of those histologic changes.
METHODS: Ten calves were implanted with a CFRVAD for 29 ± 7 days, and we compared pulmonary artery samples and hemodynamic data before and after CFRVAD implantation prospectively.
RESULTS: After implantation, the pulsatility index (pulmonary arterial pulse pressure/pulmonary arterial mean pressure) significantly decreased (0.88 ± 0.40 before vs 0.51 ± 0.22 after; p < 0.05), with severe periarteritis of the intrapulmonary arteries in all animals. Periarterial pathology included hyperplasia and inflammatory cell infiltration. The number of inflammatory cells positive for the angiotensin II type 1 receptor was significantly higher after implantation (7.8 ± 6.5 pre-CFRVAD vs 313.2 ± 145.2 at autopsy; p < 0.01). Serum angiotensin-converting enzyme activity significantly decreased after implantation from 100% to 49.7 ± 17.7% at week 1 (p = 0.01). Tissue levels of angiotensin-converting enzyme also demonstrated a significant reduction (0.381 ± 0.232 before implantation vs 0.123 ± 0.096 at autopsy; p = 0.043).
CONCLUSIONS: Periarteritis occurred in the intrapulmonary arteries of calves after CFRVAD implantation. The local renin-angiotensin system (not the angiotensin-converting enzyme pathway) plays an important role in such changes.
Copyright © 2013 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23731607      PMCID: PMC3885324          DOI: 10.1016/j.athoracsur.2013.04.008

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  16 in total

1.  Distribution of obstructive intimal lesions and their cellular phenotypes in chronic pulmonary hypertension. A morphometric and immunohistochemical study.

Authors:  E S Yi; H Kim; H Ahn; J Strother; T Morris; E Masliah; L A Hansen; K Park; P J Friedman
Journal:  Am J Respir Crit Care Med       Date:  2000-10       Impact factor: 21.405

2.  Effects of continuous flow left ventricular assist device support on skin tissue microcirculation and aortic hemodynamics.

Authors:  Kenneth N Litwak; Shin'ichiro Kihara; Marina V Kameneva; Philip Litwak; Arkady Uryash; Zhongjun Wu; Bartley P Griffith
Journal:  ASAIO J       Date:  2003 Jan-Feb       Impact factor: 2.872

Review 3.  The peptide hormone angiotensin II: its new functions in tissues and organs.

Authors:  Po Sing Leung
Journal:  Curr Protein Pept Sci       Date:  2004-08       Impact factor: 3.272

4.  Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury.

Authors:  J S Powell; J P Clozel; R K Müller; H Kuhn; F Hefti; M Hosang; H R Baumgartner
Journal:  Science       Date:  1989-07-14       Impact factor: 47.728

5.  The germinal isozyme of angiotensin-converting enzyme can substitute for the somatic isozyme in maintaining normal renal structure and functions.

Authors:  Sean P Kessler; Janette B Gomos; Thomas S Scheidemantel; Theresa M Rowe; Heather L Smith; Ganes C Sen
Journal:  J Biol Chem       Date:  2001-11-26       Impact factor: 5.157

6.  Effects of angiotensin II and vasopressin on human smooth muscle cells in vitro.

Authors:  M Campbell-Boswell; A L Robertson
Journal:  Exp Mol Pathol       Date:  1981-10       Impact factor: 3.362

7.  Smooth muscle cell hypertrophy of renal cortex arteries with chronic continuous flow left ventricular assist.

Authors:  Shin'ichiro Kihara; Kenneth N Litwak; Larry Nichols; Philip Litwak; Marina V Kameneva; Zhongjun Wu; Robert L Kormos; Bartley P Griffith
Journal:  Ann Thorac Surg       Date:  2003-01       Impact factor: 4.330

8.  Maintenance of normal blood pressure and renal functions are independent effects of angiotensin-converting enzyme.

Authors:  Sean P Kessler; Preenie deS Senanayake; Thomas S Scheidemantel; Janette B Gomos; Theresa M Rowe; Ganes C Sen
Journal:  J Biol Chem       Date:  2003-06-06       Impact factor: 5.157

9.  Development of DexAide right ventricular assist device: update II.

Authors:  Kiyotaka Fukamachi; Diyar Saeed; Alex L Massiello; David J Horvath; Hideyuki Fumoto; Tetsuya Horai; Roula Zahr; Shanaz Shalli; Tomohiro Anzai; Raymond Dessoffy; Jacquelyn Catanese; Ji-Feng Chen; Qun Zhou; Stephen Benefit; Sue Alfini; Leonard A R Golding
Journal:  ASAIO J       Date:  2008 Nov-Dec       Impact factor: 2.872

10.  Reduced pulsatility induces periarteritis in kidney: role of the local renin-angiotensin system.

Authors:  Chiyo Ootaki; Michifumi Yamashita; Yoshio Ootaki; Keiji Kamohara; Stephan Weber; Ryan S Klatte; William A Smith; Alex L Massiello; Steven N Emancipator; Leonard A R Golding; Kiyotaka Fukamachi
Journal:  J Thorac Cardiovasc Surg       Date:  2008-05-19       Impact factor: 5.209

View more
  2 in total

1.  Letter to the Editor regarding the article "Left ventricular assist devices: a kidney's perspective".

Authors:  Timothy K Cooper
Journal:  Heart Fail Rev       Date:  2015-11       Impact factor: 4.214

2.  The role of renin-angiotensin system in patients with left ventricular assist devices.

Authors:  Alexandros Briasoulis; Ernesto Ruiz Duque; Dimitrios Mouselimis; Anastasios Tsarouchas; Constantinos Bakogiannis; Paulino Alvarez
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2020 Oct-Dec       Impact factor: 1.636

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.